Search clinical trials for: Zirconium-89 crefmirlimab berdoxam
Total 18 results
-
AstraZenecaImaginAb, Inc.TerminatedCarcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Colorectal CancerUnited States, Canada
-
ImaginAb, Inc.University of HullRecruiting
-
ImaginAb, Inc.RecruitingMelanoma | Renal Cell Carcinoma | Non Small Cell Lung Cancer | Merkel Cell Carcinoma, UnspecifiedUnited States, Australia, Belgium, Netherlands, Switzerland, United Kingdom
-
Abramson Cancer Center at Penn MedicineImaginAb, Inc.Enrolling by invitation
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingLymphoma | Metastatic Malignant Solid NeoplasmUnited States
-
Radboud University Medical CenterCompleted
-
National Institute of Neurological Disorders and...RecruitingMultiple Sclerosis | Progressive Multifocal LeukoencephalopathyUnited States
-
Radboud University Medical CenterPfizer; ImaginAb, Inc.; University Hospital TuebingenNot yet recruitingNSCLCGermany, Netherlands
-
Nerissa T. ViolaNot yet recruitingNon Small Cell Lung CancerUnited States
-
Michael TopfRecruitingHead and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and NeckUnited States
-
Amsterdam UMC, location VUmcCristal TherapeuticsCompleted
-
Robert Flavell, MD, PhDNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Hoffmann-La RocheCompleted
-
Radboud University Medical CenterAstraZenecaCompletedNon-small Cell Lung CancerNetherlands
-
Leiden University Medical CenterRecruiting
-
Jonsson Comprehensive Cancer CenterTelix Pharmaceuticals (Innovations) Pty LimitedNot yet recruitingClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
Andrei IagaruNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSquamous Cell Carcinoma of the Head and Neck | Carcinoma of the Head and NeckUnited States
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands